These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


578 related items for PubMed ID: 2784998

  • 21. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
    Hein DW, Kirlin WG, Ogolla F, Trinidad A.
    Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
    [Abstract] [Full Text] [Related]

  • 22. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
    Mattano SS, Land S, King CM, Weber WW.
    Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
    [Abstract] [Full Text] [Related]

  • 23. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM.
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [Abstract] [Full Text] [Related]

  • 24. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
    Hein DW, Doll MA, Rustan TD, Ferguson RJ.
    Cancer Res; 1995 Aug 15; 55(16):3531-6. PubMed ID: 7627960
    [Abstract] [Full Text] [Related]

  • 25. The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype.
    Flammang TJ, Yamazoe Y, Guengerich FP, Kadlubar FF.
    Carcinogenesis; 1987 Dec 15; 8(12):1967-70. PubMed ID: 3677322
    [Abstract] [Full Text] [Related]

  • 26. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ, Doll MA, Gray K, Feng Y, Hein DW.
    Toxicol Appl Pharmacol; 1997 Feb 15; 142(2):360-6. PubMed ID: 9070359
    [Abstract] [Full Text] [Related]

  • 27. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
    Chung JG, Levy GN, Weber WW.
    Drug Metab Dispos; 1993 Feb 15; 21(6):1057-63. PubMed ID: 7905384
    [Abstract] [Full Text] [Related]

  • 28. Inheritance of acetylator genotype-dependent arylamine N-acetyltransferase in hamster bladder cytosol.
    Hein DW, Kirlin WG, Yerokun T, Trinidad A, Ogolla F.
    Carcinogenesis; 1987 May 15; 8(5):647-52. PubMed ID: 3581423
    [Abstract] [Full Text] [Related]

  • 29. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA, Xiao GH, Hein DW.
    Toxicol Sci; 2009 Jan 15; 107(1):293-7. PubMed ID: 18842621
    [Abstract] [Full Text] [Related]

  • 30. Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells.
    Lu KH, Lin KL, Hsia TC, Hung CF, Chou MC, Hsiao YM, Chung JG.
    Res Commun Mol Pathol Pharmacol; 2001 Jan 15; 109(5-6):319-31. PubMed ID: 12889515
    [Abstract] [Full Text] [Related]

  • 31. Polymorphic acetylation of arylamines and DNA-adduct formation.
    Weber WW, Levy GN, Martell KJ.
    Princess Takamatsu Symp; 1990 Jan 15; 21():119-26. PubMed ID: 2134671
    [Abstract] [Full Text] [Related]

  • 32. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ, Kadlubar FF.
    Carcinogenesis; 1986 Jun 15; 7(6):919-26. PubMed ID: 3708755
    [Abstract] [Full Text] [Related]

  • 33. Effects of vitamin C on arylamine N-acetyltransferase activity in human liver tumor cells.
    Wu LT, Chung JG.
    Anticancer Res; 1998 Jun 15; 18(5A):3481-6. PubMed ID: 9858928
    [Abstract] [Full Text] [Related]

  • 34. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
    Grant DM, Mörike K, Eichelbaum M, Meyer UA.
    J Clin Invest; 1990 Mar 15; 85(3):968-72. PubMed ID: 2312737
    [Abstract] [Full Text] [Related]

  • 35. Arylamine N-acetyltransferase activity of the human placenta.
    Derewlany LO, Knie B, Koren G.
    J Pharmacol Exp Ther; 1994 May 15; 269(2):756-60. PubMed ID: 8182542
    [Abstract] [Full Text] [Related]

  • 36. Ellagic [correction of ellagica] acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).
    Lin SS, Hung CF, Tyan YS, Yang CC, Hsia TC, Yang MD, Chung JG.
    Urol Res; 2001 Dec 15; 29(6):371-6. PubMed ID: 11828989
    [Abstract] [Full Text] [Related]

  • 37. Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells.
    Frederickson SM, Hatcher JF, Reznikoff CA, Swaminathan S.
    Carcinogenesis; 1992 Jun 15; 13(6):955-61. PubMed ID: 1600616
    [Abstract] [Full Text] [Related]

  • 38. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl.
    Feng Y, Fretland AJ, Rustan TD, Jiang W, Becker WK, Hein DW.
    Toxicol Appl Pharmacol; 1997 Nov 15; 147(1):56-62. PubMed ID: 9356307
    [Abstract] [Full Text] [Related]

  • 39. In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice.
    Sugamori KS, Brenneman D, Grant DM.
    Drug Metab Dispos; 2006 Oct 15; 34(10):1697-702. PubMed ID: 16815960
    [Abstract] [Full Text] [Related]

  • 40. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
    Hein DW, Doll MA, Nerland DE, Fretland AJ.
    Mol Carcinog; 2006 Apr 15; 45(4):230-8. PubMed ID: 16482518
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.